shock

Circulatory shock encompasses cardiogenic, distributive, hypovolaemic, and obstructive subtypes, all characterised by tissue hypoperfusion and cellular energy failure. Haemodynamic monitoring, vasopressor support, and identification and treatment of the underlying cause are central to management. The role of corticosteroids, vitamin C, and emerging immune-modulating strategies in septic shock continues to generate clinical trial activity.